Try GOLD - Free
Felix Pharma Eyes $250 Mn Stake Sale of Pet Drug Unit
Mint Mumbai
|February 25, 2025
Ireland-based Felix Pharmaceuticals is looking to sell a controlling stake in its Indian subsidiary, Felix Generics, which makes veterinary drugs for 'companion pets' such as dogs and cats, three people with knowledge of the development said.
Felix Pharmaceuticals, which is eyeing a valuation of around $200-250 million for a 51% stake in its Gurugram-based subsidiary, is in talks with mid-sized and buyout private equity (PE) firms for the deal, the people cited above said on condition of anonymity.
The first person cited above said the company has appointed investment bank Lincoln International to help it look for investors. According to the person, Felix is likely to sell at least 51% to a PE firm. The second person added that even after the deal, the founders will retain a sizeable stake and will continue to run the business alongside the PE investor.
"The deal will help the company raise primary capital alongside secondary exit to the founders," the first person said.
This story is from the February 25, 2025 edition of Mint Mumbai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Mumbai
Mint Mumbai
In India's car labs, Chinese models new benchmark
Walk into the vehicle development centre of any major Indian carmaker and you'll find dozens of rival cars stripped to their bones, engineers poring over every exposed circuit, nut and wire. Such 'benchmark-ing' helps companies understand why some models work while others don't, track technology trends, and plan their own vehicle roadmaps.
2 mins
November 17, 2025
Mint Mumbai
Insurance merger plan gets new life
Centre weighs consolidating National, Oriental, United
3 mins
November 17, 2025
Mint Mumbai
India's telecom spectrum: Who actually owns it?
On 13 November, the Supreme Court reserved its order on how spectrum held by Aircel and Reliance Communications (RCom) will be treated under their insolvency proceedings. The decision will bring clarity on whether spectrum can be sold to recover dues. Mint. explores.
2 mins
November 17, 2025
Mint Mumbai
Why are India's rich finally protesting for a better life?
They stood holding English placards, some of which even had commas.
4 mins
November 17, 2025
Mint Mumbai
BJP FACES TWO TESTS: ELECTORAL & FISCAL
The mammoth win in Bihar is done and dusted. Can the Bharatiya Janata Party (BJP) now break into regional bastions in the upcoming state polls in 2026, and can it continue hiking welfare spending to garner votes?
4 mins
November 17, 2025
Mint Mumbai
Resilience spells hope as uncertainty reigns high
As trade-policy turmoil prolongs global uncertainty on an IMF index, we have some bright spots too. India should consider shifting focus from supply-side policies to demand stirrers
2 mins
November 17, 2025
Mint Mumbai
IFC, two others may pick 49% in green H₂ maker Hygenco
The World Bank's International Finance Corp. (IFC), Munich-headquartered Siemens AG, and Singapore's Fullerton Fund Management may acquire at least 49% in Gurugram-based green hydrogen manufacturer Hygenco Green Energies Pvt. Ltd, two people aware of the development said.
4 mins
November 17, 2025
Mint Mumbai
DO YOU OWN PAPER OR GOLD? THE CRITICAL FINE PRINT ON SGBS
Ow Bertie is quite chuffed that he owns Sovereign Gold Bonds (SGBs).
2 mins
November 17, 2025
Mint Mumbai
Financial sector’s report card reveals regulatory gaps
The quinquennial report cards on India’s financial sector have been issued and they present a disturbing picture.
3 mins
November 17, 2025
Mint Mumbai
NEW WAVE OF TECH IPOs LEAVES RETAIL INVESTORS AT RISK
The Indian stock markets are bracing for another wave of what the fashionable set calls 'digital IPOs'.
3 mins
November 17, 2025
Listen
Translate
Change font size